- Home
- EVTV vs PRFX Comparison
EVTV vs PRFX Comparison
Compare EVTV & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVTV | PRFX |
|---|---|---|
| Founded | 2012 | 2007 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0M | 1.8M |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | EVTV | PRFX |
|---|---|---|
| Price | $0.39 | $0.69 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.2M | 158.9K |
| Earning Date | 11-20-2025 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,696,856.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 113.69 | N/A |
| 52 Week Low | $0.33 | $0.61 |
| 52 Week High | $14.00 | $6.65 |
Technical Indicators
Market Signals| Indicator | EVTV | PRFX |
|---|---|---|
| Relative Strength Index (RSI) | 24.87 | 33.91 |
| Support Level | $0.33 | $0.61 |
| Resistance Level | $0.52 | $0.91 |
| Average True Range (ATR) | 0.13 | 0.07 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 6.45 | 18.83 |
Price Performance
Historical ComparisonAbout EVTV Envirotech Vehicles Inc.
Envirotech Vehicles Inc is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. It recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.